logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Inflammatory bowel diseases : Health care and costs in Sweden in 1994.

    Article - En anglais

    Background 

    Inflammatory bowel disease (IBD) has highly variable course and severity.

    Since comprehensive data on its impact are scarce, we analyzed all IBD care and costs in Sweden (population. 8.8 million).

    Methods 

    A cross-sectional observational study, using national registers and surveys on ambulatory care, hospital admissions, medication, sickness leave, and early retirement for IBD in 1994, was carried out.

    We calculated direct health care costs and indirect 1-year costs caused by morbidity.

    Results 

    Ambulatory care was concentrated to specialists in internal medicine at hospitals.

    One-fourth of the patients accounted for 48% of 1994 hospital admissions.

    Medication was predominantly aminosalicylates and steroids.

    Sickness leave episodes were long-on average, 6 weeks.

    Although uncommon, early retirements lasted 14 years on average.

    With regard to the underlying prevalence, the use of health care and compensations by Crohn's disease patients was two to four times that of patients with ulcerative colitis.

    Morbidity took 68% of total costs.

    Among direct costs, admissions accounted for 58%. Neither complications nor surveillance added much.

    Conclusion 

    Ulcerative colitis is twice as common as Crohn's disease.

    In health care use, these roles are reversed.

    Since morbidity causes two-thirds of the costs, comprehensive analyses, including indirect costs, are necessary when evaluating new diagnostics and therapies.

    Mots-clés Pascal : Rectocolite ulcérohémorragique, Entérite Crohn, Coût financement, Soin santé primaire, Ambulatoire, Hospitalisation, Médicament, Morbidité, Mortalité, Résultat, Homme, Appareil digestif pathologie, Intestin pathologie, Maladie inflammatoire, Economie santé, Chimiothérapie

    Mots-clés Pascal anglais : Ulcerative colitis, Crohn disease, Financing cost, Primary health care, Ambulatory, Hospitalization, Drug, Morbidity, Mortality, Result, Human, Digestive diseases, Intestinal disease, Inflammatory disease, Health economy, Chemotherapy

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0015113

    Code Inist : 002B30A04B. Création : 17/04/1998.